Defective Glucagon-Like Peptide 1 Secretion in Prediabetes and Type 2 Diabetes Is Influenced by Weight and Sex. Chicken, Egg, or None of the Above?: Figure 1

Diabetes - United States
doi 10.2337/db15-0292
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Impaired Cardiometabolic Responses to Glucagon-Like Peptide 1 in Obesity and Type 2 Diabetes Mellitus

Basic Research in Cardiology
Cardiovascular MedicinePhysiologyCardiology
2013English

GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2015English

Glucagon-Like Peptide 1 Receptor Agonists: A New Approach to Type 2 Diabetes Management

South African Family Practice
2013English

Correction To: Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features

Clinical Drug Investigation
MedicinePharmacology
2020English

Glucagon-Like Peptide-1 Analogues and Anxiety and Abnormal Eating Behaviours in Type 2 Diabetes: A Case Report

Journal of Diabetes & Metabolism
2014English

Inappropriate Glucagon and GLP-1 Secretion in Individuals With Long-Standing Type 1 Diabetes: Effects of Residual C-Peptide

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Glucagon-Like Peptide-1 and Satiety

Nature
Multidisciplinary
1997English

Glucagon-Like Peptide Analogues for Type 2 Diabetes Mellitus

2007English

Stiff Person Syndrome and Type 1 Diabetes Mellitus: A Case of the Chicken or the Egg?

Journal of General Internal Medicine
Internal Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy